Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$4.63bn	211.5	n/a
MSBMesoblast	AU$2.83bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$1.04bn	n/a	n/a
PYCPYC Therapeutics	AU$715.44m	n/a	n/a
IMMImmutep	AU$335.89m	n/a	n/a
DXBDimerix	AU$308.23m	n/a	n/a
CGSCogstate	AU$297.31m	20.1	1.12%
RACRace Oncology	AU$279.73m	n/a	n/a
TTXTetratherix	AU$200.82m	n/a	n/a
PEBPacific Edge	NZ$129.91m	n/a	n/a
ATHAlterity Therapeutics	AU$114.09m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$105.15m	n/a	n/a
LTPLtr Pharma	AU$104.97m	n/a	n/a
ALAArovella Therapeutics	AU$99.84m	n/a	n/a
BXNBioxyne	AU$86.59m	17.54	n/a
ACWActinogen Medical	AU$85.78m	n/a	n/a
ILAIsland Pharmaceuticals	AU$69.65m	n/a	n/a
ATXAmplia Therapeutics	AU$64.01m	n/a	n/a
IMUImugene	AU$62.36m	n/a	n/a
ADOAnteotech	AU$62.22m	n/a	n/a